Regulated expression of human beta-defensin-2 leads to altered phenotype and growth patterns of cultured human embryonal kidney cells

Experimental Oncology

Volumn 28, Issue 4, 2006, Pages 288-292

  Zhuravel, E ^a   Lytvyn, D ^a   Soldatkina, M ^a   Zeleniy, S ^a   Shestakova, T ^a   Pogrebnoy, P ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Colony formation; HEK293 cells; Human beta defensin 2; Regulated expression

Indexed keywords

AGAR; BETA DEFENSIN 2; MESSENGER RNA; TETRACYCLINE;

ARTICLE; CELL GROWTH; CELL STRUCTURE; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; EMBRYO CELL; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BETA-DEFENSINS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CLONING, MOLECULAR; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 33846874177     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human {beta}-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006; 66: 8542-9.
2. Shnitsar VM, Lisovskiy IL, Soldatkina MA, Nespryadko SV, Turchak OV, Vinnitskaya AB, Pogrebniy PV. Human beta-defensin 3 (hBD-3) expression in A431 cell line and human vulval tumors. Exp Oncol 2004; 26: 328-30.
3. Arimura Y, Ashitani J, Yanagi S, Tokojima M, Abe K, Mukae H, Nakazato M. Elevated serum beta-defensins concentrations in patients with lung cancer. Anticancer Res 2004; 24: 4051-7.
4. Gambichler T, Skrygan M, Huyn J, Bechara FG, Sand M, Altmeyer P, Kreuter A. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. BMC Cancer 2006; 6: 163.
5. Muller CA, Markovic-Lipkovski J, Klatt T, Gamper J, Schwarz G, Beck H, Deeg M, Kalbacher H, Widmann S, Wessels JT, Becker V, Muller GA, Flad T. Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol 2002; 160: 1311-24.
6. Melle C, Ernst G, Schimmel B, Bleul A, Thieme H, Kaufmann R, Mothes H, Settmacher U, Claussen U, Halbhuber KJ, Von Eggeling F. Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 2005; 129: 66-73.
7. Albrethsen J, Bogebo R, Gammeltoft S, Olsen J, Winther B, Raskov H. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 2005; 5: 8.
8. Kamysz W, Okroj M, Lukasiak J. Novel properties of antimicrobial peptides. Acta Biochim Pol 2003; 50: 461-9.
9. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155: 408-13.
10. Markeeva N, Lisovskiy I, Zhuravel E, Soldatkina M, Lyzogubov V, Usenko V, Potapov V, Pogrebnoy P. Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix. Exp Oncol 2005; 27: 308-14.
11. Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Cirica A, Semmes OJ, Vlahou A. Overexpression of alpha-defensin is associated with bladder cancer invasiveness. Urol Oncol 2006; 24: 97-108.
12. Aarboiu J, Tjabringa GS, Verhoosel RM, Ninaber DK, White SR, Peltenburg LT, Rabe KF, Hiemstra PS. Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm Res 2006; 55: 119-27.
13. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2002; 22: 2103-7.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
15. Maniatis T, Frich E, Sambrook J. Molecular cloning. Moskow: Mir, 1984; p. 423 (In Russian).
16. Markeeva N, Lisovskiy I, Lyzogubov W, Usenko V, Soldatkina M, Merentsev S, Zaitsev S, Kondratskii Yu, Tofan A, Osinskiy S, Pogrebnoy P. Expression of beta-defensin-2 in human gastric tumors: a pilot study. Exp Oncol 2005; 27: 130-5.
17. Xu MJ, Tsuji K, Ueda T, Mukouyama YS, Hara T, Yang FC, Ebihara Y, Matsuoka S, Manabe A, Kikuchi A, Ito M, Miyajima A, Nakahata T. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derivedstromal cell lines. Blood 1998; 92: 2032-40.
18. Liu L, Wang L, Jia HP, Zhao C, Heng HHQ, Schutte BC, McCray PB Jr, Ganz T. Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation Gene 1998; 222 (2), 237-244.
19. Mahimkar RM, Visaya O, Pollock AS, Lovett DH. The disintegrin domain of ADAM9: a ligand for multiple b1 renal integrins. Biochem J 2005; 385: 461-8.
20. Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J, Lu W, Preissner KT, Hammes HP, Chavakis T. Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood 2005; 106: 3831-8.
21. Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, Bdeir K. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J 2004; 18: 1306-8.